Strategic research a must says Dr Ayyappan
BioPharma | News | By Rahul Koul Koul | 0 Comment | 01 May, 2014
"For every single rupee invested in last five years so far in technolo...Read more
Eli Lilly, AstraZeneca to develop a drug for Alzheimers
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2014
Eli Lilly and AstraZeneca (AZ) have announced a joint collaboration t...Read more
WHO report: Antibiotic resistance poses serious threat to public health
BioPharma | Reports/white papers | By BioSpectrum Bureau | 0 Comment | 01 May, 2014
A new report by the World Health Organization (WHO) - the first to loo...Read more
Quality at an affordable price is a challenge
BioPharma | News | 0 Comment | 11 Oct, 2011
Dr SD Ravetkar Senior director, Seru...Read more
These three decades were worth it, says Dr Rao
BioPharma | Features | By Rahul Koul Koul | 0 Comment | 04 Apr, 2015
The rotavirus vaccine was launched on March 09, 2015 by the Prime Mini...Read more
Sun Pharma settles litigation for drug
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 15 May, 2014
Sun Pharmaceutical Industries Ltd. announced that one of its subsidiar...Read more
Dr Reddy's, BioMarin settle patent issue
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 22 Sep, 2015
BioMarin Pharmaceutical has announced that it has entered into a settl...Read more
Lupin inks strategic JV agreement with Yoshindo
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2014
Pharma Major, Lupin Limited announced today that it has entered into a...Read more
Lupin acquires Pharma Dynamics
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 17 Mar, 2015
Lupin has entered into an agreement to acquire the balance 40 percent ...Read more
Lupin appoints Theresa Stevens as chief corporate development officer
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 22 Apr, 2014
Pharma major Lupin announced the appointment of Theresa Stevens as Chi...Read more
Compulsory licensing: A nightmare awaiting pharma MNCs?
BioPharma | Features | By BioSpectrum Bureau | 0 Comment | 26 Jul, 2015
Saxagliptin (Onglyza) is a drug used in treating type-2 diabetes. Init...Read more
Dr LH Hiranandani Hospital to host IBOM 2014 in Mumbai
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 17 Apr, 2014
Dr L H Hiranandani Hospital will host the International Biologics Orth...Read more
Jubilant Life Sciences to participate in VIV India 2014
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 22 Apr, 2014
Jubilant Life Sciences, the worldwide second largest manufacturer of N...Read more
'Government needs to invest $5 bn per year'
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2014
"To make bio-manufacturing the next big thing after generics for India...Read more
Lupin to market Novartis' Inhaler in India
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 13 Apr, 2016
Pharma Major Lupin Limited (Lupin) and Novartis Healthcare Private Lim...Read more
Pharma companies furious over price control order
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2014
The NPPA has identified more drugs used in the treatment of cancer, ca...Read more
Sigvaris appoints NovoMed as distributor in India
BioPharma | News | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2014
Sigvaris, a leading international medical device company and the world...Read more
Not enough for SME innovators in the union budget
BioPharma | News | By Rahul Koul Koul | 0 Comment | 17 Jul, 2014
While the government has now removed the tax on services by way of tec...Read more